Scott John Dagarno

Title: Scott John Dagarno: Innovator in Pharmaceutical Crystal Transformation

Introduction

Scott John Dagarno is a notable inventor based in Edinburgh, GB. He has made significant contributions to the field of pharmaceuticals through his innovative methods for transforming pharmaceutical crystal forms. His work is particularly relevant in enhancing the efficacy and stability of pharmaceutical agents.

Latest Patents

Dagarno holds a patent for a method that provides a gas-induced technique for phase-transforming organic solids, specifically pharmaceutical crystals. The patent, titled "Method for transforming pharmaceutical crystal forms," describes a process that subjects polymorphs of pharmaceutical agents to various pressures of gases, such as CO, NO, and CH, to induce phase transformation with ease. This innovative approach has the potential to improve the manufacturing and performance of pharmaceutical products.

Career Highlights

Scott John Dagarno is affiliated with the University of Missouri, where he continues to advance research in pharmaceutical sciences. His work has garnered attention for its practical applications in the pharmaceutical industry, particularly in the development of more effective drug formulations.

Collaborations

Dagarno has collaborated with esteemed colleagues, including Jian Tian and Jerry Lee Atwood. These partnerships have contributed to the advancement of research in the field and have fostered a collaborative environment for innovation.

Conclusion

Scott John Dagarno's contributions to pharmaceutical science through his innovative patent demonstrate his commitment to improving drug formulation processes. His work continues to influence the industry and pave the way for future advancements in pharmaceuticals.